Nipah Virus: Current Research Focus, Viral Biology, and Tools Supporting Ongoing Studies

4th Feb 2026

Nipah virus (NiV) is a zoonotic RNA virus belonging to the Henipavirus genus within the Paramyxoviridae family. First identified during an outbreak in Malaysia in 1998–1999, Nipah virus has since caused sporadic but recurrent outbreaks across South and Southeast Asia. Human infection is associated with severe encephalitis and respiratory disease, with high case fatality rates reported across outbreaks [1,2].

Nipah virus remains a priority for studies, largely due to the absence of licensed vaccines or targeted antiviral therapies, and the limited understanding of protective immune responses. [3].

Viral Structure and Key Targets for Neutralisation

Nipah virus is an enveloped, negative-sense single-stranded RNA virus. Its genome encodes six major structural proteins, several of which play central roles in viral pathogenesis and immune recognition [4].

  • Glycoprotein (G) – Mediates viral attachment to host cell receptors (ephrin-B2 and ephrin-B3). The G protein is a primary target for neutralising antibodies and vaccine development [5,6].
  • Fusion protein (F) – Drives membrane fusion following receptor engagement. Neutralising antibodies targeting F can block viral entry [6].
  • Nucleocapsid protein (N) – Encapsidates viral RNA and is abundantly expressed during infection. Due to its conservation and immunogenicity, N is widely used in diagnostics, serological assays, and research applications[7].
  • Phosphoprotein (P) and accessory proteins (V and W) – Involved in viral replication and immune evasion, particularly through interference with interferon signalling pathways [8].

Current Situation: Why Nipah Virus Research Is Highly Relevant Now

Recurrent Nipah virus outbreaks in India, particularly in the southern state of Kerala, have reinforced that NiV represents an ongoing scientific challenge rather than a historical or geographically isolated event. Repeated spillover events and outbreak investigations have highlighted persistent gaps in understanding viral diversity, transmission, and host response [9,10].

Why Nipah Virus Research Matters for Human Health

Nipah virus research is essential for informing the development of vaccines, therapeutics, and diagnostics. Critical unanswered questions include the identification of protective immune correlates, determinants of neurological disease, and the conservation of neutralising epitopes across circulating strains [6,11].

Experimental Approaches Used in Nipah Virus Research

Current research relies on molecular and immunological techniques that frequently use recombinant proteins or non-infectious systems to characterise viral proteins and host immune responses [7,12].

  • Immunofluorescence and immunocytochemistry for localisation of viral proteins
  • Western blotting for detection and characterisation of viral antigens
  • ELISA and serological assays to assess antibody responses
  • Recombinant protein-based assays for antigen validation and assay development

Supporting Nipah Virus Research with Validated Immunological Tools

As research activity surrounding Nipah virus increases, access to well-characterised immunological reagents is critical. St John’s Laboratory supplies antibodies, secondary detection reagents, and recombinant viral proteins designed to support reproducible research into Nipah virus and related henipaviruses.

References

  1. Chua KB et al. Nipah virus: a recently emergent deadly paramyxovirus. Science. 2000.
  2. Lo MK, Rota PA. The emergence of Nipah virus, a highly pathogenic paramyxovirus. J Clin Virol. 2008.
  3. World Health Organization. R&D Blueprint: Priority Diseases. WHO.
  4. Harcourt BH et al. Molecular characterization of Nipah virus. Virology. 2001.
  5. Bonaparte MI et al. Ephrin-B2 ligand is a functional receptor for Nipah virus. PNAS. 2005.
  6. Dang HV et al. Broadly neutralizing antibodies against Nipah virus. Nat Struct Mol Biol. 2019.
  7. Daniels P et al. Antigenic properties of Nipah virus nucleocapsid protein. J Gen Virol. 2001.
  8. Shaw ML et al. Nipah virus V and W proteins inhibit interferon signaling. J Virol. 2004.
  9. Arunkumar G et al. Outbreak investigation of Nipah virus disease in Kerala, India. Emerg Infect Dis. 2019.
  10. Sudeep AB et al. Nipah virus infection in India: epidemiology and control. Indian J Med Res. 2020.
  11. Broder CC et al. Henipavirus neutralization and vaccine development. Curr Opin Virol. 2016.
  12. Clayton BA et al. Nipah virus research models and reagents. Viruses. 2018.
!